| Mitochondrial Function and Pathology | Lifetime | 58 | ES 1 | 99.69 |
| Neuroinflammation and Neurodegeneration Mechanisms | Lifetime | 46 | ES 2 | 99.73 |
| Neuroscience and Neuropharmacology Research | Lifetime | 91 | ES 2 | 99.82 |
| Alzheimer's disease research and treatments | Lifetime | 58 | ES 1 | 99.83 |
| RNA regulation and disease | Lifetime | 27 | ES 2 | 99.45 |
| Prion Diseases and Protein Misfolding | Lifetime | 13 | ES 1 | 99.56 |
| Neurological diseases and metabolism | Lifetime | 18 | ES 1 | 99.63 |
| Parkinson's Disease Mechanisms and Treatments | Lifetime | 74 | ES 2 | 99.70 |
| Genetic Neurodegenerative Diseases | Lifetime | 53 | ES 3 | 99.50 |
| S100 Proteins and Annexins | Lifetime | 61 | ES 2 | 98.96 |
| Cell death mechanisms and regulation | Lifetime | 79 | ES 1 | 99.27 |
| Alcoholism and Thiamine Deficiency | Lifetime | 28 | ES 1 | 98.57 |
| Neurogenesis and neuroplasticity mechanisms | Lifetime | 118 | ES 5 | 99.23 |
| Neonatal and fetal brain pathology | Lifetime | 136 | ES 3 | 98.87 |
| Amyotrophic Lateral Sclerosis Research | Lifetime | 83 | ES 1 | 98.81 |
| Cellular transport and secretion | Lifetime | 230 | ES 4 | 98.64 |
| Genetics and Neurodevelopmental Disorders | Lifetime | 301 | ES 6 | 98.30 |
| Biochemical effects in animals | Lifetime | 266 | ES 11 | 97.91 |
| Trace Elements in Health | Lifetime | 305 | ES 4 | 97.94 |
| Nuclear Receptors and Signaling | Lifetime | 113 | ES 1 | 98.07 |
| Nerve injury and regeneration | Lifetime | 272 | ES 3 | 98.23 |
| RNA Research and Splicing | Lifetime | 769 | ES 8 | 97.94 |
| Cholinesterase and Neurodegenerative Diseases | Lifetime | 270 | ES 6 | 97.89 |
| Neuromodulation and Treatments for Neurological Disorders | Lifetime | 462 | ES 14 | 98.02 |
| Neurological and metabolic disorders | Lifetime | 133 | ES 3 | 96.98 |
| Anesthesia and Neurotoxicity Research | Lifetime | 557 | ES 2 | 96.79 |
| Endoplasmic Reticulum Stress and Disease | Lifetime | 522 | ES 3 | 96.77 |
| Fetal and Pediatric Neurological Disorders | Lifetime | 385 | ES 4 | 96.60 |
| Muscle Physiology and Disorders | Lifetime | 645 | ES 11 | 96.73 |
| Neurogenetic and Muscular Disorders Research | Lifetime | 512 | ES 1 | 95.72 |
| Neurological Disease Mechanisms and Treatments | Lifetime | 568 | ES 8 | 95.67 |
| Cerebrovascular and genetic disorders | Lifetime | 123 | ES 1 | 95.18 |
| Cannabis and Cannabinoid Research | Lifetime | 896 | ES 41 | 94.56 |
| Lysosomal Storage Disorders Research | Lifetime | 771 | ES 20 | 93.71 |
| Calpain Protease Function and Regulation | Lifetime | 188 | ES 2 | 92.02 |
| Hereditary Neurological Disorders | Lifetime | 788 | ES 14 | 89.79 |
| 14-3-3 protein interactions | Lifetime | 385 | ES 9 | 87.02 |
| Nuclear Structure and Function | Lifetime | 989 | ES 26 | 86.12 |
| Ginkgo biloba and Cashew Applications | Lifetime | 522 | ES 11 | 83.69 |
| Down syndrome and intellectual disability research | Lifetime | 996 | ES 63 | 73.97 |
| Prion Diseases and Protein Misfolding | 2021-2025 | 14 | ES 1 | 95.88 |
| Alzheimer's disease research and treatments | 2021-2025 | 174 | ES 9 | 98.12 |
| Mitochondrial Function and Pathology | 2021-2025 | 136 | ES 4 | 95.55 |
| Neuroinflammation and Neurodegeneration Mechanisms | 2021-2025 | 197 | ES 3 | 96.09 |
| Neuroscience and Neuropharmacology Research | 2021-2025 | 268 | ES 10 | 95.13 |
| Neurological diseases and metabolism | 2021-2025 | 43 | ES 1 | 94.21 |
| Amyotrophic Lateral Sclerosis Research | 2021-2025 | 213 | ES 4 | 91.78 |
| Neurogenetic and Muscular Disorders Research | 2021-2025 | 237 | ES 5 | 92.26 |
| Endoplasmic Reticulum Stress and Disease | 2021-2025 | 390 | ES 5 | 83.08 |
| Cholinesterase and Neurodegenerative Diseases | 2021-2025 | 603 | ES 14 | 79.04 |
| Cholesterol and Lipid Metabolism | 2021-2025 | 819 | ES 49 | 53.05 |
